Insider Transactions in Q2 2022 at Prelude Therapeutics Inc (PRLD)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2022
|
Laurent Chardonnet Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+28.99%
|
$40,000
$4.23 P/Share
|